Skip to content
Gaudium IVF & Women Health logo

Gaudium IVF & Women Health

Gaudium IVF and Women Health Ltd

GAUDIUMIVF NSE
₹107.22 −0.71 (−0.66%)
P/E
30.55
View as Markdown
MCP
Close 4 Nov 2026 ₹107.22 +26.96 +33.6% since 27 Feb 2026
Start ₹80.26

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
29.30%
Debt to Equity
0.16
EPS (TTM)
₹3.51
Book Value
₹20.92
Market Cap
—
P/E (TTM)
30.55
P/B
5.13
ROE
24.70%
Dividend Yield
0.00%
EBITDA
₹38.20 Cr
52W High
₹163.18
52W Low
₹69.18
Day Range
₹105.50 – ₹108.81
Volume
1,99,975

Peer Comparison

Healthcare › Healthcare Service Provider

Gaudium IVF & Women Health peer comparison
Dr Lal Pathlabs
₹2,029.4062.75₹32,036 Cr13.580.26%22.30%28.00%₹2,891 Cr₹545 Cr
Vijaya Diagnostic Centre
₹1,424.6078.15₹14,588 Cr15.330.14%18.30%20.50%₹857 Cr₹187 Cr
Metropolis Healthcare
₹581.2559.74₹11,437 Cr8.030.88%13.60%17.80%₹1,710 Cr₹203 Cr
Thyrocare Technologies
₹495.5044.72₹7,723 Cr14.252.90%28.40%35.40%₹876 Cr₹176 Cr
Nephrocare Health Services
₹622.35148.53₹5,903 Cr5.610.00%8.83%15.30%₹1,053 Cr₹85 Cr
Suraksha Diagnostic
₹333.0548.41₹1,717 Cr7.080.15%14.20%17.30%₹325 Cr₹35 Cr
Krsnaa Diagnostics
₹483.0515.84₹1,571 Cr1.510.41%10.90%12.70%₹726 Cr₹98 Cr
Gaudium IVF & Women Health (this company)
₹107.2230.55₹781 Cr5.130.00%24.70%29.30%₹106 Cr₹23 Cr
Median 8 companies₹538.3854.08₹6,813 Cr7.560.21%16.25%19.15%₹867 Cr₹137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Key Insights

Strengths

1
  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has high debtors of 187 days.
  • Working capital days have increased from 39.9 days to 90.9 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish586
OscillatorsBullish162
Moving AveragesNeutral424

Key readings

RSI (14)
52.64
Neutral
MACD (12,26,9)
−1.39
Bullish
SMA (50)
110.37
Bearish
SMA (200)
—
Neutral

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
3Y+33.21%
1Y+46.48%

Net profit

Net profit growth by window
3Y+19.68%
1Y+26.32%

Operating cash flow

Operating cash flow growth by window
3Y−33.68%
1Y−22.22%

Operating margin· change in pp

Operating margin growth by window
3Y−8.91 pp
1Y−4.31 pp

Trailing twelve months: Fewer than eight quarters are reported, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2022₹37.00 Cr
Mar 2023₹44.00 Cr
Mar 2024₹48.00 Cr
Mar 2025₹71.00 Cr
Mar 2026₹104 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2022₹9.00 Cr
Mar 2023₹14.00 Cr
Mar 2024₹10.00 Cr
Mar 2025₹19.00 Cr
Mar 2026₹24.00 Cr

Quarterly Results

₹ Cr
GAUDIUMIVF quarterly results, ₹ crore
Particulars Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
14.42
26.92
17.76
31.73
24.51
30.35
19.38
Expenses
8.76
18.2
12.61
17.96
17.95
18.18
16.95
Operating Profit
5.66
8.72
5.15
13.77
6.56
12.17
2.43
OPM %
39.25%
32.39%
29%
43.4%
26.76%
40.1%
12.54%
Other Income
0
0.23
0
0.15
0.1
0.18
1.12
Interest
0.39
0.43
0.5
0.51
1.2
1.29
0.38
Depreciation
0.58
0.36
0.61
0.61
0.49
0.64
0.72
PBT
4.69
8.16
4.04
12.8
4.96
10.42
2.45
Tax %
27.72%
20.96%
24.01%
26.64%
26.96%
19.77%
27.76%
Net Profit
3.4
6.46
3.07
9.38
3.63
8.36
1.78
EPS (₹)
0.55
1.05
0.5
1.53
0.59
1.15
0.24

Profit & Loss

₹ Cr
GAUDIUMIVF profit and loss, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
37
44
48
71
104
106
Expenses
23
24
28
42
67
71
Operating Profit
14
20
19
29
38
35
OPM %
37%
46%
41%
41%
36%
33%
Other Income
0
0
0
0
0
2
Interest
1
0
1
2
3
3
Depreciation
1
1
2
2
3
2
PBT
12
18
17
25
32
31
Tax %
26%
26%
38%
25%
24%
—
Net Profit
9
14
10
19
24
23
EPS (₹)
89.17
137
104
3.12
3.36
3.51
Div. Payout %
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
GAUDIUMIVF balance sheet, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.99
0.99
0.99
31
36
Reserves
8
22
26
16
116
Borrowings
6
12
17
21
25
Other Liabilities
3
2
7
22
16
Total Liabilities
18
37
51
89
193
Fixed Assets
4
18
19
18
30
CWIP
0
0
0
7
0
Investments
0
0
0
5
5
Other Assets
14
18
32
58
158
Total Assets
18
37
51
89
193

Cash Flow

₹ Cr
GAUDIUMIVF cash flow, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−1
24
3
9
7
Investing
−1
−16
−5
−15
−88
Financing
3
5
−1
2
82
Net Cash Flow
0
13
−3
−5
2
Free Cash Flow
−2
9
1
0
5
CFO/OP
13
141
27
46
51

Ratios

GAUDIUMIVF financial ratios, annual
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
65
8
104
170
187
Inventory Days
29
111
168
175
38
Days Payable
114
77
62
338
133
Cash Conversion Cycle
−20
41
210
7
92
Working Capital Days
61
−52
−15
44
91
ROCE %
—
76%
45%
49%
29%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Gaudium IVF & Women Health insights

57 extracted metrics across FY22–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 71.29%
  • Public 18.19%
  • Others 7.10%
  • DIIs 2.22%
  • FIIs 1.19%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Gaudium IVF & Women Health

What does Gaudium IVF and Women Health Ltd do?
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.
Where is Gaudium IVF and Women Health Ltd (GAUDIUMIVF) listed?
Gaudium IVF and Women Health Ltd trades as GAUDIUMIVF on the NSE and under code 544709 on the BSE.
Which sector does Gaudium IVF and Women Health Ltd belong to?
Gaudium IVF and Women Health Ltd is classified under the Healthcare sector, in the Healthcare Service Provider industry.
What is the PE ratio of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd trades at a PE ratio of 30.55 as of 4 Nov 2026, on earnings per share of ₹3.51, against a book value of ₹20.92 per share.
What is the 52-week high and low of Gaudium IVF and Women Health Ltd?
Over the last 52 weeks Gaudium IVF and Women Health Ltd has traded between ₹69.18 and ₹163.18 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd reported a return on equity of 24.70%. Its debt-to-equity ratio is 0.16.

Company Information

Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.

Website gaudiumivfcentre.com
Listed 27 Feb 2026
Face Value ₹5

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GAUDIUMIVF.md for Gaudium IVF and Women Health Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month